During the last 20 years, five intrinsic molecular subtypes of breast cancer (Luminal A, Luminal B, human epidermal growth factor receptor 2 (HER2)-enriched, Basal-like and Claudin-low) have been identified as a result of activation of these genes [4]. Here, ERBB2 is linked to breast cancer.